COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS
The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptabl...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | XU, WEI DEMORIN, FRENEL SHAKYA, SAGAR WANG, YONG SHAH, KHALID |
| description | The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptable salt thereof.
La présente invention concerne des inhibiteurs de tyrosine kinase de formule I et le composé 1, ou des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne en outre des procédés de préparation des inhibiteurs de tyrosine kinase, de formule I et du composé 1, ou d'un sel pharmaceutiquement acceptable de ceux-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3235602A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3235602A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3235602A13</originalsourceid><addsrcrecordid>eNrjZLB09vcN8A_1cwlWcPMPUgjxcFUICXJ1DPF19QtR8HdT8Pb0cwx21XVxDXD1cwGJuXgG-we5uAYF8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeGdHYyNjUzMDI0dDYyKUAABEsihH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS</title><source>esp@cenet</source><creator>XU, WEI ; DEMORIN, FRENEL ; SHAKYA, SAGAR ; WANG, YONG ; SHAH, KHALID</creator><creatorcontrib>XU, WEI ; DEMORIN, FRENEL ; SHAKYA, SAGAR ; WANG, YONG ; SHAH, KHALID</creatorcontrib><description>The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptable salt thereof.
La présente invention concerne des inhibiteurs de tyrosine kinase de formule I et le composé 1, ou des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne en outre des procédés de préparation des inhibiteurs de tyrosine kinase, de formule I et du composé 1, ou d'un sel pharmaceutiquement acceptable de ceux-ci.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230511&DB=EPODOC&CC=CA&NR=3235602A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230511&DB=EPODOC&CC=CA&NR=3235602A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>XU, WEI</creatorcontrib><creatorcontrib>DEMORIN, FRENEL</creatorcontrib><creatorcontrib>SHAKYA, SAGAR</creatorcontrib><creatorcontrib>WANG, YONG</creatorcontrib><creatorcontrib>SHAH, KHALID</creatorcontrib><title>COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS</title><description>The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptable salt thereof.
La présente invention concerne des inhibiteurs de tyrosine kinase de formule I et le composé 1, ou des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne en outre des procédés de préparation des inhibiteurs de tyrosine kinase, de formule I et du composé 1, ou d'un sel pharmaceutiquement acceptable de ceux-ci.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB09vcN8A_1cwlWcPMPUgjxcFUICXJ1DPF19QtR8HdT8Pb0cwx21XVxDXD1cwGJuXgG-we5uAYF8zCwpiXmFKfyQmluBgU31xBnD93Ugvz41OKCxOTUvNSSeGdHYyNjUzMDI0dDYyKUAABEsihH</recordid><startdate>20230511</startdate><enddate>20230511</enddate><creator>XU, WEI</creator><creator>DEMORIN, FRENEL</creator><creator>SHAKYA, SAGAR</creator><creator>WANG, YONG</creator><creator>SHAH, KHALID</creator><scope>EVB</scope></search><sort><creationdate>20230511</creationdate><title>COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS</title><author>XU, WEI ; DEMORIN, FRENEL ; SHAKYA, SAGAR ; WANG, YONG ; SHAH, KHALID</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3235602A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>XU, WEI</creatorcontrib><creatorcontrib>DEMORIN, FRENEL</creatorcontrib><creatorcontrib>SHAKYA, SAGAR</creatorcontrib><creatorcontrib>WANG, YONG</creatorcontrib><creatorcontrib>SHAH, KHALID</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>XU, WEI</au><au>DEMORIN, FRENEL</au><au>SHAKYA, SAGAR</au><au>WANG, YONG</au><au>SHAH, KHALID</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS</title><date>2023-05-11</date><risdate>2023</risdate><abstract>The present disclosure relates to tyrosine kinase inhibitors of Formula I and Compound 1, or pharmaceutically acceptable salts thereof. The present disclosure further relates to processes for the preparation of the tyrosine kinase inhibitors, Formula I and Compound 1, or a pharmaceutically acceptable salt thereof.
La présente invention concerne des inhibiteurs de tyrosine kinase de formule I et le composé 1, ou des sels pharmaceutiquement acceptables de ceux-ci. La présente invention concerne en outre des procédés de préparation des inhibiteurs de tyrosine kinase, de formule I et du composé 1, ou d'un sel pharmaceutiquement acceptable de ceux-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3235602A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | COMPOUNDS FOR THE TREATMENT OF KINASE-DEPENDENT DISORDERS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T23%3A39%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=XU,%20WEI&rft.date=2023-05-11&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3235602A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |